Table 3b.
OR (95% CI), n = 445 | |||
---|---|---|---|
Analyte | Univariate | Model 1 | Model 2 |
Age, scaled to 10 years | 1.30 (1.13, 1.51) | 1.36 (1.16, 1.60) | 1.33 (1.12, 1.58) |
Sex | |||
Male | Ref. | Ref. | Ref. |
Female | 1.96 (1.30, 2.98) | 2.32 (1.49, 3.66) | 2.54 (1.59, 4.14) |
Race | |||
White | Ref. | Ref. | Ref. |
Non-white | 0.82 (0.49, 1.33) | 0.78 (0.45, 1.31) | 0.72 (0.41, 1.24) |
BMI | |||
<30 | Ref. | Ref. | Ref. |
≥30 | 1.49 (0.98, 2.25) | 1.45 (0.92, 2.26) | 1.30 (0.81, 2.09) |
Vaccine Status | |||
None | Ref. | Ref. | Ref. |
Partially or fully | 0.71 (0.42, 1.15) | 0.69 (0.40, 1.16) | 0.71 (0.40, 1.20) |
Diabetes | |||
No | Ref. | Ref. | Ref. |
Yes | 1.41 (0.72, 2.71) | 0.95 (0.44, 1.99) | 1.10 (0.49, 2.44) |
CCP transfused | |||
>5 days since symptom onset | Ref. | Ref. | Ref. |
≤5 days since symptom onset | 0.69 (0.46, 1.03) | 0.64 (0.41, 0.98) | 0.60 (0.38, 0.95) |
Log10 IL-6, pg/mL | - | - | 1.91 (1.03, 3.56) |
Note: P<0.05 were highlighted in bold. Model 1 include age, sex, race, BMI, vaccine status, diabetes, and the time between CCP transfusion and illness onset. Model 2 additionally include log10 IL-6 Abbreviations: CCP: COVID-19 convalescent plasma. BMI: body mass index. PCC: post COVID-19 conditions at day 90.